Recall
FDAHealthMay 28, 2025

Pfizer Inc. — DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, In

⚠️ Discoloration; discolored solution from cracked vials

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
May 28, 2025

Nationwide in the USA

What's affected?

Product
DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62
Lot code
KA5023

Additional details

Lot KA5023, exp 02/28/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 98,410 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.